Panel Session Medication Development for Addictions: New Approaches.Published in:2004Publication type:Abstract
Abstracts of the 43rd Annual Meeting of the American College of Neuropsychopharmacology (ACNP). December 12-16, 2004, San Juan, Puerto Rico.Published in:Neuropsychopharmacology, 2004, v. 29, p. S1Publication type:Article
Panel Session The Bed Nucleus of the Stria Terminalis: Where Stress and Anxiety Meet Drug Abuse.Published in:2004Publication type:Abstract
Panel Session Functional Neuroimaging in Bipolar and Unipolar Disorders.Published in:2004Publication type:Abstract
Panel Session Face to Face: Face Processing in Health and in Schizophrenia.Published in:2004Publication type:Abstract
Panel Session Physiological Functions and Therapeutic Potential of Metabotropic Glutamate 5 (mGlu5) Receptors.Published in:2004Publication type:Abstract
Panel Session Non-5-HT Components of the Midbrain Raphe Nuclei: Implications for Stress and Psychotherapy.Published in:2004Publication type:Abstract
Panel Session Neurobiological Consequences of Chronic Marijuana Exposure: A Translational View.Published in:2004Publication type:Abstract
Panel Session Schizophrenia Genes Implicate Convergent Signaling Pathways.Published in:2004Publication type:Abstract
Panel Session Differential Sensitivity & Intermediate Phenotype The Role of Genes in Behavior.Published in:2004Publication type:Abstract
Panel Session Novel Serotonin Transporter Gene Promoter Variants and Psychiatric Illness.Published in:2004Publication type:Abstract
Panel Session Synaptic Biology of Mood Disorders and their Treatment.Published in:2004Publication type:Abstract
Panel Session New Vistas in Corticotropin-Releasing Factor (CRF) Neurbiology.Published in:2004Publication type:Abstract
Panel Session The Hippocampus in Fear and Anxiety: A Neglected Portion of the Neural Fear Circuitry.Published in:2004Publication type:Abstract
Panel Session Reevaluation of Stimulant-related Growth Suppression in the Treatment of ADHD.Published in:2004Publication type:Abstract
Panel Session Accelerators and Regulators of G Protein Signaling: New Targets for Psychiatric Disorders.Published in:2004Publication type:Abstract
Panel Session Drug Development: Serotonin's Role in Modulating Drug Reward and Relapse.Published in:2004Publication type:Abstract
Panel Session Of Mice and Men: Serotonin Genes from the Cage to the Clinic.Published in:2004Publication type:Abstract
Panel Session Drug Development: Developing Drugs for Cognitive Pathology in Schizophrenia.Published in:2004Publication type:Abstract
Panel Session ECNP Panel: Brain GABA-A Receptors — 25 Years of Progress.Published in:2004Publication type:Abstract
Panel Session Deep Brain Stimulation as a Putative Treatment for Refractory Major Depression — Neuroanatomy, Neurocircuitry, Neuroimaging and First Clinical Findings.Published in:2004Publication type:Abstract
Panel Session Functional Organization of Cortical Activities During Visual Processing in Schizophrenia.Published in:2004Publication type:Abstract
Panel Session Drug Development: Novel Approaches to CNS Drug Discovery: Allosterism, Interfaces and Receptoromics.Published in:2004Publication type:Abstract
Panel Session Myelinating Glial Cells in Psychiatric Disorders.Published in:2004Publication type:Abstract
Panel Session Neurbiology of Obesity: Relations to Addiction.Published in:2004Publication type:Abstract
Panel Session Neuroendocrine Signaling in Adolescence: Relevance to Mental Health.Published in:2004Publication type:Abstract
Panel Session New Insights into Panic Disorder: Basic and Clinical Studies.Published in:2004Publication type:Abstract
Panel Session Cognition, Emotion, and the Prefrontal Cortex: Integrating Studies in Humans and Nonhuman Primates.Published in:2004Publication type:Abstract
Panel Session Predictors of Treatment Response and Relapse: Neurobiological Markers.Published in:2004Publication type:Abstract
Panel Session Molecular Genetics of Addiction Vulnerability and Treatment Responses.Published in:2004Publication type:Abstract
Panel Session PET Imaging of Transfected and Endogenous Gene Expression.Published in:2004Publication type:Abstract
Panel Session SSRI Medications and Cognitive-Behavioral Therapy in Children and Adolescents.Published in:2004Publication type:Abstract
Panel Session Drug Development: Therapeutic Role of D3 Receptor Drugs in Schizophrenia, Neuroprotection, and Drug Addiction.Published in:2004Publication type:Abstract
Panel Session Complex Cortical-Basal Ganglia Neural Networks: 3-D Reconstructions in Rate and Monkey Help Understand the Network That Underlies Disease and Therapeutic Intervention.Published in:2004Publication type:Abstract
Panel Session Mechanisms of Hippocampal Involvement in the Pathophysiology of Schizophrenia.Published in:2004Publication type:Abstract
Panel Session Drug Development: The Delayed Onset of Antipsychotics Action-Fact or Fiction.Published in:2004Publication type:Abstract